Literature DB >> 1413838

Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.

T Okamoto1, Y Fujimoto, T Obara, Y Ito, M Aiba.   

Abstract

To determine the factors causing thyroid dysfunction after surgery for Graves' disease, we studied 321 patients who underwent subtotal thyroidectomy during the 7-year period from 1981 to 1987. Thyroid functional status was evaluated biochemically and the patients were divided into four categories: recurrent hyperthyroidism, euthyroidism, latent hypothyroidism, and hypothyroidism. The following factors were analyzed: sex, age at onset of the disease, indication for surgery, serum titer of antimicrosomal hemagglutination antibody (MCHA), weight of resected thyroid tissue, size of remnant thyroid relative to body surface area, pathological findings of lymphoid follicles, and lymphocytic infiltration in the thyroid tissue. Probabilities of failure (recurrent hyperthyroidism and hypothyroidism) were estimated by the Kaplan-Meier method. Prognostic factors for failure were identified by using Cox's proportional hazards model. The incidence of hyperthyroidism and hypothyroidism 5 years after subtotal thyroidectomy was 16.2% and 9.6%, respectively. Significant factors for hyperthyroidism were relatively large thyroid remnant, high serum titer of MCHA (greater than or equal to 1:3200), and age at onset of the disease less than 20 years. The significant factor for hypothyroidism was severe lymphocytic infiltration. The level of postoperative thyroid stimulating hormone (TSH)-binding inhibition immunoglobulins (TBII) in patients with recurrence was significantly higher than in patients in remission. It is reasonable to determine the amount of remnant thyroid tissue in relation to patient body surface area. Although subtotal thyroidectomy can induce immunological remission by reduction of antigen, if the remission disappears, that is if TBII increases, recurrence of hyperthyroidism may develop even in patients without the unfavorable factors.

Entities:  

Mesh:

Year:  1992        PMID: 1413838     DOI: 10.1007/bf02067359

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  33 in total

1.  Current trends in the management of Graves' disease.

Authors:  B Solomon; D Glinoer; R Lagasse; L Wartofsky
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

2.  Retrospective reevaluation of the significance of thyroid microsomal antibody in the treatment of Graves' disease.

Authors:  N Hamada; K Ito; T Mimura; N Ishikawa; N Momotani; J Noh; Y Hosoda; H Morii
Journal:  Acta Endocrinol (Copenh)       Date:  1987-03

3.  Thyroid function after subtotal thyroidectomy for hyperthyroidism related to some morphological and immunological features.

Authors:  B Lundström; J Hed; K E Johansson; K Norrby
Journal:  Acta Chir Scand       Date:  1977

4.  The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease.

Authors:  N R Steel; J J Taylor; E T Young; J R Farndon; M Holcombe; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  1987-01       Impact factor: 3.478

5.  The influence of remnant size, antithyroid antibodies, thyroid morphology, and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism.

Authors:  E Jörtsö; S Lennquist; B Lundström; K Norrby; S Smeds
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

6.  Lymphoid tissue in the thyroid gland and thymus of patients with primary thyrotoxicosis.

Authors:  J S Beck; R J Young; J G Simpson; E S Gray; A G Nicol; C A Pegg; W Michie
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

7.  Hyperthyroidism associated with histologic Hashimoto's thyroiditis.

Authors:  V Fatourechi; W M McConahey; L B Woolner
Journal:  Mayo Clin Proc       Date:  1971-10       Impact factor: 7.616

8.  Follow-up evaluation of thyroid function after thyroidectomy for thyrotoxicosis.

Authors:  T Harada; K Shimaoka; S Arita; Y Nakanishi
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

9.  Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases.

Authors:  D Sugrue; M McEvoy; J Feely; M I Drury
Journal:  Q J Med       Date:  1980

10.  Surgical treatment for Graves' disease: a long term follow-up of 325 patients.

Authors:  S Noguchi; N Murakami; A Noguchi
Journal:  Br J Surg       Date:  1981-02       Impact factor: 6.939

View more
  8 in total

1.  Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism.

Authors:  Johannes Järhult; Per-Olof Andersson; Linda Duncker
Journal:  Langenbecks Arch Surg       Date:  2011-12-09       Impact factor: 3.445

2.  Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

3.  Subtotal thyroidectomy for benign multinodular goiter: a 6-month postoperative study of the remnant's function and sonographic aspect.

Authors:  Fawzy Bakiri; Menad Hassaïm; Mohamed-Sadreddine Bourouba
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

4.  A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves' disease.

Authors:  Shun-Yu Chi; Kun-Chou Hsei; Shyr-Ming Sheen-Chen; Fong-Fu Chou
Journal:  World J Surg       Date:  2005-01-18       Impact factor: 3.352

5.  Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.

Authors:  Pablo Moreno; José M Gómez; Núria Gómez; José M Francos; Emilio Ramos; Antonio Rafecas; E Jaurrieta
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

6.  Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; Y Kure; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

7.  Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism.

Authors:  E J Limonard; P H Bisschop; E Fliers; E J Nieveen van Dijkum
Journal:  ScientificWorldJournal       Date:  2012-02-01

8.  Incidences of Hypothyroidism Associated With Surgical Procedures for Thyroid Disorders: A Nationwide Population-Based Study.

Authors:  Shin-Han Tsai; Shuo-Chen Chien; Phung-Anh Nguyen; Po-Han Chien; Hon-Ping Ma; Rahma Novita Asdary; Yao-Chin Wang; Ayesha Humayun; Chen-Ling Huang; Usman Iqbal; Wen-Shan Jian
Journal:  Front Pharmacol       Date:  2019-12-12       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.